Molecular analysis of minimal residual disease in adult acute lymphoblastic leukaemiaFORONI, Letizia; HOFFBRAND, A. Victor.Baillière's best practice & research. Clinical haematology. 2002, Vol 15, Num 1, pp 71-90, issn 1521-6926Article

Core binding factor genes and human leukemiaHART, Stephen M; FORONI, Letizia.Haematologica (Roma). 2002, Vol 87, Num 12, pp 1307-1323, issn 0390-6078, 17 p.Article

Minimal Residual Disease Investigation in Haematological MalignanciesFORONI, Letizia; HOFFBRAND, Victor.Baillière's best practice & research. Clinical haematology. 2002, Vol 15, Num 1, issn 1521-6926, 233 p.Serial Issue

Clinical relevance of MRD in children undergoing allogeneic stem cell transplantation for ALLGOULDEN, Nick; STEWARD, Colin.Baillière's best practice & research. Clinical haematology. 2002, Vol 15, Num 1, pp 59-70, issn 1521-6926Article

The significance of minimal residual disease in patients with t(15;17)GRIMWADE, David.Baillière's best practice & research. Clinical haematology. 2002, Vol 15, Num 1, pp 137-158, issn 1521-6926Article

Monitoring disease in lymphoma and CLL patients using molecular techniquesGRIBBEN, John G.Baillière's best practice & research. Clinical haematology. 2002, Vol 15, Num 1, pp 179-195, issn 1521-6926Article

Minimal residual disease in acute myeloid leukaemiaLIU YIN, J. A.Baillière's best practice & research. Clinical haematology. 2002, Vol 15, Num 1, pp 119-135, issn 1521-6926Article

Minimal residual disease in chronic myeloid leukaemia patientsHOCHHAUS, Andreas.Baillière's best practice & research. Clinical haematology. 2002, Vol 15, Num 1, pp 159-178, issn 1521-6926Article

Molecular measurement of minimal residual disease in Philadelphia-positive acute lymphoblastic leukaemiaRADICH, Jerald P.Baillière's best practice & research. Clinical haematology. 2002, Vol 15, Num 1, pp 91-103, issn 1521-6926Article

Advances in the immunological monitoring of childhood acute lymphoblastic leukaemiaCAMPANA, Dario; COUSTAN-SMITH, Elaine.Baillière's best practice & research. Clinical haematology. 2002, Vol 15, Num 1, pp 1-19, issn 1521-6926Article

Monitoring minimal residual disease using chromosomal translocations in childhood ALLCAZZANIGA, Giovanni; ROSSI, Vincenzo; BIONDI, Andrea et al.Baillière's best practice & research. Clinical haematology. 2002, Vol 15, Num 1, pp 21-35, issn 1521-6926Article

BCL10 deletions in haematological malignancies : a cloning artefact?DUKE, Veronioue; KAPOOR, Aarti; GRICKS, Clair et al.British journal of haematology. 2000, Vol 111, Num 4, pp 1106-1108, issn 0007-1048Article

Analysis of balanced rearrangements of chromosome 6 in acute leukemia : clustered breakpoints in q22-q23 and possible involvement of c-MYB in a new recurrent translocation, t(6;7)(q23;q32-36)SINCLAIR, Paul B; HARRISON, Christine J; JAROSOVA, Marie et al.Haematologica (Roma). 2005, Vol 90, Num 5, pp 602-611, issn 0390-6078, 10 p.Article

Efficacy of combining dasatinib and FLAG-IDA for patients with chronic myeloid leukemia in blastic transformationMILOJKOVIC, Dragana; IBRAHIM, Amr; REID, Alistair et al.Haematologica (Roma). 2012, Vol 97, Num 3, pp 473-474, issn 0390-6078, 2 p.Article

Immunological evaluation of minimal residual disease (MRD) in acute myeloid leukaemia (AML)SAN-MIGUEL, Jesus F; VIDRIALES, Maria B; ORFAO, Alberto et al.Baillière's best practice & research. Clinical haematology. 2002, Vol 15, Num 1, pp 105-118, issn 1521-6926Article

Somatically mutated regions of immunoglobulin on human b-cell lymphomas code for peptides that bind to autologous major histocompatibility complex class I, providing a potential target for cytotoxic T cellsGRICKS, Clair S; RAWLINGS, Eira; FORONI, Letizia et al.Cancer research (Baltimore). 2001, Vol 61, Num 13, pp 5145-5152, issn 0008-5472Article

Target enrichment and high-throughput sequencing of 80 ribosomal protein genes to identify mutations associated with Diamond-Blackfan anaemiaGERRARD, Gareth; VALGANON, Mikel; FORONI, Letizia et al.British journal of haematology. 2013, Vol 162, Num 4, pp 530-536, issn 0007-1048, 7 p.Article

Assessment of BCR-ABL1 Transcript Levels at 3 Months Is the Only Requirement for Predicting Outcome for Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase InhibitorsMARIN, David; IBRAHIM, Amr R; PAVLU, Jiri et al.Journal of clinical oncology. 2012, Vol 30, Num 3, pp 232-238, issn 0732-183X, 7 p.Article

Responses to second-line tyrosine kinase inhibitors are durable: an intention-to-treat analysis in chronic myeloid leukemia patientsMILOJKOVIC, Dragana; APPERLEY, Jane F; MARIN, David et al.Blood. 2012, Vol 119, Num 8, pp 1838-1843, issn 0006-4971, 6 p.Article

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL) : analysis of cytogenetic data from patients treated on the medical research council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. CommentaryAPPELBAUM, Frederick R; MOORMAN, Anthony V; FIELDING, Adele K et al.Blood. 2007, Vol 109, Num 8, issn 0006-4971, 3127,3189-3197 [10 p.]Article

Immunoglobulin heavy-chain gene rearrangement in adult acute lymphoblastic leukemia reveals preferential usage of J_H-proximal variable gene segmentsMORTUZA, Forida Y; MOREIRA, Ilidia M; FORONI, Letizia et al.Blood. 2001, Vol 97, Num 9, pp 2716-2726, issn 0006-4971Article

Adherence Is the Critical Factor for Achieving Molecular Responses in Patients With Chronic Myeloid Leukemia Who Achieve Complete Cytogenetic Responses on ImatinibMARIN, David; BAZEOS, Alexandra; PALIOMPEIS, Christos et al.Journal of clinical oncology. 2010, Vol 28, Num 14, pp 2381-2388, issn 0732-183X, 8 p.Article

Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemiaMILOJKOVIC, Dragana; NICHOLSON, Emma; KHORASHAD, Jamshid S et al.Haematologica (Roma). 2010, Vol 95, Num 2, pp 224-231, issn 0390-6078, 8 p.Article

Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993PATEL, Bella; RAI, Lena; FIELDING, Adele K et al.British journal of haematology. 2010, Vol 148, Num 1, pp 80-89, issn 0007-1048, 10 p.Article

Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutationsBENCH, Anthony J; WHITE, Helen E; CLENCH, Tim et al.British journal of haematology. 2013, Vol 160, Num 1, pp 25-34, issn 0007-1048, 10 p.Article